Company Filing History:
2 out of 1,746 
2 out of 24 
Years Active: 2004-2006
Title: The Innovations of Serge Piettre: Pioneering Anti-Inflammatory Compounds
Introduction: Serge Piettre, an accomplished inventor based in Saint Martin l'Hortier, France, has made significant contributions to the field of medicinal compounds. With three patents to his name, his work primarily focuses on the development of anti-inflammatory medications that target crucial biological processes.
Latest Patents: Among his latest innovations, Piettre has developed compounds that inhibit leukotriene A (LTA), an enzyme involved in the biosynthesis of leukotriene LTB, a known pro-inflammatory mediator. This invention not only reveals the therapeutic anti-inflammatory applications of these compounds but also includes methods for their preparation. Additionally, he has created LTA4 hydrolase inhibitors that share similar therapeutic and anti-inflammatory applications, further demonstrating his commitment to advancing medical treatment for inflammatory conditions.
Career Highlights: Throughout his career, Serge Piettre has worked with noted organizations such as Bioprojet and the Institut National de la Santé Et de La Recherche Médicale (Inserm). These positions have allowed him to refine his research and contribute to meaningful advancements in the biomedical field.
Collaborations: Piettre's innovative journey has been enriched by collaborations with esteemed colleagues, including Denis Danvy and Thierry Monteil. These partnerships have played a vital role in the development of his patents and innovations.
Conclusion: Serge Piettre's dedication to inventing anti-inflammatory compounds showcases his expertise and impact in the pharmaceutical field. With a solid patent portfolio and notable collaborations, his work continues to pave the way for future advancements in medicinal treatments.